Search Results - "SORIANO, V."

Refine Results
  1. 1

    Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs by Altice, Frederick L, Prof, Kamarulzaman, Adeeba, Prof, Soriano, Vincent V, Prof, Schechter, Mauro, Prof, Friedland, Gerald H, Prof

    Published in The Lancet (British edition) (31-07-2010)
    “…Summary HIV-infected drug users have increased age-matched morbidity and mortality compared with HIV-infected people who do not use drugs. Substance-use…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Optimization of Lipid Nanoparticles for saRNA Expression and Cellular Activation Using a Design-of-Experiment Approach by Ly, Han Han, Daniel, Simon, Soriano, Shekinah K. V., Kis, Zoltán, Blakney, Anna K.

    Published in Molecular pharmaceutics (06-06-2022)
    “…Lipid nanoparticles (LNPs) are the leading technology for RNA delivery, given the success of the Pfizer/BioNTech and Moderna COVID-19 mRNA (mRNA) vaccines, and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Hepatitis B virus escape mutants induced by antiviral therapy by Sheldon, Julie, Soriano, Vincent

    Published in Journal of antimicrobial chemotherapy (01-04-2008)
    “…The hepatitis B virus (HBV) polymerase and envelope genes overlap in such a way that resistance mutations to antiviral agents in the reverse transcriptase gene…”
    Get full text
    Journal Article
  6. 6

    Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients by Fernández-Montero, José Vicente, Vispo, Eugenia, Barreiro, Pablo, Sierra-Enguita, Rocío, de Mendoza, Carmen, Labarga, Pablo, Soriano, Vincent

    Published in Clinical infectious diseases (01-06-2014)
    “…Background. Coinfection with hepatitis viruses is common in individuals infected with human immunodeficiency virus (HIV) and has become a leading cause of…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV‐infected adults by Rockstroh, JK, Bhagani, S, Benhamou, Y, Bruno, R, Mauss, S, Peters, L, Puoti, M, Soriano, V, Tural, C

    Published in HIV medicine (01-02-2008)
    “…Objectives With the decline in HIV‐associated morbidity and mortality following the introduction of highly active antiretroviral therapy (HAART), liver disease…”
    Get full text
    Journal Article
  10. 10

    Predictors of in-hospital mortality in HIV-infected patients with COVID-19 by Moreno-Torres, V, de Mendoza, C, Martínez-Urbistondo, M, Mills, P, Treviño, A, de la Fuente, S, Díaz de Santiago, A, Calderón-Parra, J, Pintos-Pascual, I, Corpas, M, Soriano, V

    Published in QJM : An International Journal of Medicine (14-02-2023)
    “…Underlying immunodeficiency is associated with severe COVID-19, but the prognosis of persons with human immunodeficiency virus (HIV) (PWH) with COVID-19 is…”
    Get full text
    Journal Article
  11. 11

    Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy by Soriano, Vicente, Moreno-Torres, Victor, Treviño, Ana, Corral, Octavio, de Mendoza, Carmen

    Published in Drug design, development and therapy (01-01-2023)
    “…It has been ten years since the identification of NTCP as the cell surface receptor for HBV and HDV entry into hepatocytes. The search for molecules…”
    Get full text
    Journal Article
  12. 12

    Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients by Fernández-Montero, J. V., Barreiro, P., de Mendoza, C., Labarga, P., Soriano, V.

    Published in Journal of viral hepatitis (01-01-2016)
    “…Summary Patients infected with HIV are at increased risk for cardiovascular disease despite successful antiretroviral therapy. Likewise, chronic hepatitis C…”
    Get full text
    Journal Article
  13. 13

    Directly acting antivirals against hepatitis C virus by Soriano, Vincent, Vispo, Eugenia, Poveda, Eva, Labarga, Pablo, Martin-Carbonero, Luz, Fernandez-Montero, Jose Vicente, Barreiro, Pablo

    Published in Journal of antimicrobial chemotherapy (01-08-2011)
    “…The approval of directly acting antivirals (DAA) for the treatment of chronic hepatitis C virus (HCV) infection will represent a major breakthrough for the 180…”
    Get full text
    Journal Article
  14. 14

    Mutations affecting the replication capacity of the hepatitis B virus by Sheldon, J., Rodès, B., Zoulim, F., Bartholomeusz, A., Soriano, V.

    Published in Journal of viral hepatitis (01-07-2006)
    “…The genetic variability of the hepatitis B virus (HBV) encounters two compounding forces: a high viral copy number produced during active replication and the…”
    Get full text
    Journal Article
  15. 15

    Component-resolved diagnosis of vespid venom-allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitization by Monsalve, R. I., Vega, A., Marqués, L., Miranda, A., Fernández, J., Soriano, V., Cruz, S., Domínguez-Noche, C., Sánchez-Morillas, L., Armisen-Gil, M., Guspí, R., Barber, D.

    Published in Allergy (Copenhagen) (01-04-2012)
    “…Background Cross‐reactivity between hymenoptera species varies according to the different allergenic components of the venom. The true source of sensitization…”
    Get full text
    Journal Article
  16. 16

    Phase I–II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma by Plummer, R, Lorigan, P, Brown, E, Zaucha, R, Moiseyenko, V, Demidov, L, Soriano, V, Chmielowska, E, Andrés, R, Kudryavtseva, G, Kahatt, C, Szyldergemajn, S, Extremera, S, de Miguel, B, Cullell-Young, M, Calvert, H

    Published in British journal of cancer (17-09-2013)
    “…Background: This phase I–II trial compared plitidepsin 1-h infusion alone or combined with dacarbazine (DTIC) 1-h infusion as front-line therapy for advanced…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain by Requena, S, Lozano, A B, Caballero, E, García, F, Nieto, M C, Téllez, R, Fernández, J M, Trigo, M, Rodríguez-Avial, I, Martín-Carbonero, L, Miralles, P, Soriano, V, de Mendoza, C

    Published in Journal of antimicrobial chemotherapy (01-05-2019)
    “…HIV-2 is a neglected virus despite estimates of 1-2 million people being infected worldwide. The virus is naturally resistant to some antiretrovirals used to…”
    Get full text
    Journal Article
  19. 19

    Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection by Gupta, P, Liu, B, Wu, J.Q, Soriano, V, Vispo, E, Carroll, A.P, Goldie, B.J, Cairns, M.J, Saksena, N.K

    Published in Virology (New York, N.Y.) (01-02-2014)
    “…Abstract Co-infection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) is common due to shared transmission routes. The genomic basis of…”
    Get full text
    Journal Article
  20. 20